Terms: = Endocrine gland cancer AND NCOA2, TIF2, 10499, ENSG00000140396, NCoA-2, MGC138808
13 results:
1. Uterine Tumors Resembling Ovarian Sex Cord Tumors (UTROSCTs): A Scoping Review of 511 Cases, Including 2 New Cases.
Watrowski R; Palumbo M; Guerra S; Gallo A; Zizolfi B; Giampaolino P; Bifulco G; Di Spiezio Sardo A; De Angelis MC
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38276058
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological features and molecular genetic changes in 17 cases of uterine tumor resembling ovarian sex cord tumor.
Qijun C; Wei W; Cheng W; Dongni L
Hum Pathol; 2024 Jan; 143():33-41. PubMed ID: 38000680
[TBL] [Abstract] [Full Text] [Related]
3. A Case of Uterine Tumor Resembling Ovarian Sex Cord Tumor With Prominent Myxoid Features.
Ise K; Tanei ZI; Oda Y; Tanikawa S; Sugino H; Ishida Y; Tsuda M; Gotoda Y; Nishiwaki K; Yanai H; Hasegawa T; Nagashima K; Tanaka S
Int J Gynecol Pathol; 2024 Jan; 43(1):41-46. PubMed ID: 37406360
[TBL] [Abstract] [Full Text] [Related]
4. Uterine Tumor Resembling Ovarian Sex Cord Tumors: 23 Cases Indicating Molecular Heterogeneity With Variable Biological Behavior.
Bi R; Yao Q; Ji G; Bai Q; Li A; Liu Z; Cheng Y; Tu X; Yu L; Chang B; Huang D; Ge H; Zuo K; Li H; Chang H; Cai X; Jiang W; Zhou X; Yang W
Am J Surg Pathol; 2023 Jul; 47(7):739-755. PubMed ID: 37132508
[TBL] [Abstract] [Full Text] [Related]
5. NCOA1/2/3 rearrangements in uterine tumor resembling ovarian sex cord tumor: A clinicopathological and molecular study of 18 cases.
Lu B; Xia Y; Chen J; Tang J; Shao Y; Yu W
Hum Pathol; 2023 May; 135():65-75. PubMed ID: 36646185
[TBL] [Abstract] [Full Text] [Related]
6. Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women.
Peduzzi G; Archibugi L; Katzke V; Gentiluomo M; Capurso G; Milanetto AC; Gazouli M; Goetz M; Brenner H; Vermeulen RCH; Talar-Wojnarowska R; Vanella G; Tavano F; Lucchesi M; Mohelnikova-Duchonova B; Chen X; Kiudelis V; Hegyi P; Oliverius M; Stocker H; Stornello C; Vodickova L; Souček P; Neoptolemos JP; Testoni SGG; Morelli L; Lawlor RT; Basso D; Izbicki JR; Ermini S; Kupcinskas J; Pezzilli R; Boggi U; van Laarhoven HWM; Szentesi A; Erőss B; Capretti G; Schöttker B; Skieceviciene J; Aoki MN; van Eijck CHJ; Cavestro GM; Canzian F; Campa D
Sci Rep; 2022 Oct; 12(1):18100. PubMed ID: 36302831
[TBL] [Abstract] [Full Text] [Related]
7. Uterine Tumor Resembling Ovarian Sex Cord Tumor With Aggressive Histologic Features Harboring a GREB1-ncoa2 Fusion: Case Report With a Brief Review.
Yin X; Wang M; He H; Ru G; Zhao M
Int J Gynecol Pathol; 2023 Jan; 42(1):54-62. PubMed ID: 35081070
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological characteristics and genetic variations of uterine tumours resembling ovarian sex cord tumours.
Ye S; Wu J; Yao L; He J
J Clin Pathol; 2022 Nov; 75(11):776-781. PubMed ID: 34348985
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathologic Characterization of GREB1-rearranged Uterine Sarcomas With Variable Sex-Cord Differentiation.
Lee CH; Kao YC; Lee WR; Hsiao YW; Lu TP; Chu CY; Lin YJ; Huang HY; Hsieh TH; Liu YR; Liang CW; Chen TW; Yip S; Lum A; Kuo KT; Jeng YM; Yu SC; Chung YC; Lee JC
Am J Surg Pathol; 2019 Jul; 43(7):928-942. PubMed ID: 31094921
[TBL] [Abstract] [Full Text] [Related]
10. Pancreatic involvement by mesenchymal chondrosarcoma harboring the HEY1-ncoa2 gene fusion.
Cohen JN; Solomon DA; Horvai AE; Kakar S
Hum Pathol; 2016 Dec; 58():35-40. PubMed ID: 27544802
[TBL] [Abstract] [Full Text] [Related]
11. Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing.
De Mattos-Arruda L; Bidard FC; Won HH; Cortes J; Ng CK; Peg V; Nuciforo P; Jungbluth AA; Weigelt B; Berger MF; Seoane J; Reis-Filho JS
Mol Oncol; 2014 Feb; 8(1):150-8. PubMed ID: 24220311
[TBL] [Abstract] [Full Text] [Related]
12. STAMP alters the growth of transformed and ovarian cancer cells.
He Y; Blackford JA; Kohn EC; Simons SS
BMC Cancer; 2010 Apr; 10():128. PubMed ID: 20374646
[TBL] [Abstract] [Full Text] [Related]
13. Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain.
Eng FC; Barsalou A; Akutsu N; Mercier I; Zechel C; Mader S; White JH
J Biol Chem; 1998 Oct; 273(43):28371-7. PubMed ID: 9774463
[TBL] [Abstract] [Full Text] [Related]
